Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Sep 15, 2023
- Accession no.
- 0001209191-23-049648
- Filed
- Sep 15, 2023
- Trade date
- Sep 15, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.22M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Common Stock | MOption exerciseAcquired | +11,016 | $3.67 | +$40,428.72 | 36,113 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −11,016 | $75.19 | −$828,293.04 | 25,097 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −18,572 | $75.18 | −$1,396,242.96 | 403,856 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Common Stock | MOption exerciseDisposed | −11,016 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.